How much is DICE Therapeutics worth in 2026?

DICE Therapeutics has a current valuation of N/A based on their Later Stage VC (Series C1) round and secondary market data.

How much funding has DICE Therapeutics raised?

DICE Therapeutics has raised N/A in total funding across 1 funding rounds.

DICE Therapeutics

Drug Discovery

DICE Therapeutics valuation and funding history | Last updated: August 21, 2021 | 1 funding rounds

Current Valuation

N/A

As of August 21, 2021

Total Funding Raised

N/A

Across 1 round

Last Round

Later Stage VC (Series C1)

$60.0M

Last Funding

Aug 2021

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
August 21, 2021	Later Stage VC (Series C1)	$60.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

DICE Therapeutics is currently valued at N/A as of August 21, 2021.

Track DICE Therapeutics Valuation Updates

Get notified when DICE Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for DICE Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock DICE Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is DICE Therapeutics Worth in 2026?

DICE Therapeutics is a leading private company in the Drug Discovery sector. Track DICE Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How DICE Therapeutics Valuation is Determined

Private company valuations like DICE Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.